Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Jared Gollob Net Worth & Insider Trades

Jared Gollob - Chief Medical Officer, Kymera Therapeutics, Inc

As of March 3, 2023

What is Jared Gollob's Net Worth?

The current estimated net worth of Kymera Therapeutics, Inc's Chief Medical Officer, Jared Gollob, is estimated to be about $8.32M . Jared Gollob owns about 74,709 units of Kymera Therapeutics, Inc common stock. In the last 3 years at Kymera Therapeutics, Inc, Jared Gollob has sold an estimated value of $7.69M worth.

What is Jared Gollob's Past Insider Trading?

Jared Gollob's largest purchase order was 39,603 units , worth over $66.97K on November 2, 2021. Jared Gollob's largest sale order was 57,493 units , worth over $3.57M on November 2, 2021. In total, Jared Gollob has made about 9 transactions over 3 years of their time at Kymera Therapeutics, Inc. Jared Gollob usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 1,298 units , worth over $40.23K on March 3, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jared Gollob

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jared Gollob's' Mailing Address?

  • Mailing address is C/o Kymera Therapeutics, Inc. 200 Arsenal Yards, Suite 230 Watertown MA 02472 MA

What are Kymera Therapeutics, Inc's Past Insider Trades?

Kymera Therapeutics, Inc's most recent insider trade came on November 6, 2023 by Bvf Partners L Pil, Biotechnology Value Fund L P, Bvf I GP Llc, Biotechnology Value Fund Ii Lp, Bvf Ii GP Llc, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Bvf GP Holdings Llc, Incil Bvf and Mark Lampert who bought 414,105 units worth $5.3M . In the last 2 years, insiders at Kymera Therapeutics, Inc have sold an estimated value of $150.27M and bought an estimated value of $93.73M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Nello Mainolfi, Chief Executive Officer,  Bruce N Jacobs, Chief Financial Officer,  and Biotechnology Value Fund Ii Lp, Director .

Kymera Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...